Mike Wartell

Director/Board Member chez NU RIDE INC.

Profil

Mr. Michael J.
Wartell, CFA, is a Co-Chief Investment Officer at Venor Capital Management LP.
He is on the Board of Directors at Rotech Healthcare Holdings, Inc. and Rotech Healthcare, Inc. He is sharing the responsibility of managing the Firm’s investment program and risk management.
He has over 25 years of experience in principal investing in both high yield and distressed strategies.
Prior to founding the Firm, he was a Managing Director and co-head of the North American Distressed Research team at Deutsche Bank where he was partly responsible for investing approximately $1 billion of capital and managing the team’s research professionals.
Prior to joining Deutsche Bank in 1999, he served as Vice President/Analyst/Trader in Merrill Lynch’s Distressed Debt/Leverage Finance Group (1993 – 1999), was an analyst at Matrix Asset Advisors (1992 – 1993), and had worked as an Accountant on the Tax Staff of Arthur Andersen, LLP (1991 – 1992).
He earned a B.S.E.
(Cum Laude) with concentrations in Finance and Accounting from The Wharton School at The University of Pennsylvania in 1991.

Postes actifs de Mike Wartell

Sociétés	Poste	Début
NU RIDE INC.	Director/Board Member	14/03/2024
Venor Capital Management LP	Founder	01/07/2005
Rotech Healthcare, Inc.	Director/Board Member	-
Rotech Healthcare Holdings, Inc.	Director/Board Member	01/07/2014

Anciens postes connus de Mike Wartell

Sociétés	Poste	Fin
Deutsche Bank Corp.	Corporate Officer/Principal	31/12/2004
Merrill Lynch & Co., Inc. /Old/	Corporate Officer/Principal	01/01/1999
Matrix Asset Advisors, Inc.	Analyst-Equity	31/12/1992
Arthur Andersen LLP	Corporate Officer/Principal	01/01/1992

Formation de Mike Wartell

The Wharton School of the University of Pennsylvania

Undergraduate Degree